Archived
This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.
Abstract
All addictive substances directly or indirectly interact with the dopamine reward system to alter the brain’s dopamine receptor activities. It is essential for a truly effective addiction medication to attenuate substance reward and normalize the brain’s physiological functions. Conventional pharmacological intervention approaches to the treatment of substance addiction usually aim to develop and deliver a potential therapeutic agent to the brain to directly block or decrease actions of the substance or its therapeutic target in the brain. However, it is a grand challenge to attenuate the substance reward without affecting the normal physiological functions of brain receptors or transporters. Here, we show that peripheral ghrelin deacylation using a ghrelin deacylase identified in this study can effectively attenuate the pharmacological and rewarding effects of methamphetamine, a representative psychostimulant, in rodents through an interesting pharmacological mechanism without interacting with the ghrelin receptor or the dopamine receptor (because the ghrelin deacylase is not expected to cross the blood−brain barrier). In further animal behavioral studies, ghrelin deacylase administration significantly attenuated rat self-administration of methamphetamine, suggesting that ghrelin deacylase may serve as a promising therapeutic candidate for addiction treatment.
Document Type
Article
Publication Date
2025
Digital Object Identifier (DOI)
https://doi.org/10.1021/acsptsci.5c00391
Funding Information
This work was supported by the National Institutes of Health (NIH grants R01 DA056646, U18 DA052319, U01 DA051079, UG3/UH3 NS134920, UH2/UH3 DA041115, R01 DA035552, R01 DA032910, and R01 DA013930).
Repository Citation
Stewart, Madeline J.; Wei, Huimei; Chandar, Nellore Bhanu; Zheng, Fang; and Zhan, Chang-Guo, "Development of a Ghrelin Deacylase to Attenuate Drug Reward and Associated Effects of Methamphetamine" (2025). Pharmaceutical Sciences Faculty Publications. 218.
https://uknowledge.uky.edu/ps_facpub/218

Notes/Citation Information
© 2025 The Authors. Published by American Chemical Society